Serina Therapeutics, Inc. also files under AGE; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 22, 2026 | Simon Farrell | Director | Grant(A) | 31K | — | $0 |
| Jul 7, 2026 | Brannan Stephen K. | Director | Buy(P) | 1K | $2.03 | $2K |
| Jun 17, 2026 | Bailey Gregory | Director | Conversion(C) | 1.8M | $2.25 | $4.0M |
| Jun 17, 2026 | Wilson Karen J | Director | Grant(A) | 15K | — | $0 |
| Jun 17, 2026 | Brannan Stephen K. | Director | Grant(A) | 15K | — | $0 |
| Jun 17, 2026 | Venkatesan Jay | Director | Conversion(C) | 97K | $2.25 | $217K |
| Jun 17, 2026 | Bailey Gregory | Director | Grant(A) | 3.3M | — | $0 |
| Jun 17, 2026 | Venkatesan Jay | Director | Conversion(C) | 224K | $2.25 | $504K |
| Jun 17, 2026 | Bailey Gregory | Director | Conversion(C) | 6.7M | $2.25 | $15.0M |
| Jun 17, 2026 | Bailey Gregory | Director | Grant(A) | 15K | — | $0 |
| Jun 17, 2026 | Bailey Gregory | Director | Conversion(C) | 763K | $2.25 | $1.7M |
| Jun 17, 2026 | Marshall Richard Peter | Director | Grant(A) | 15K | — | $0 |
| Jun 17, 2026 | Venkatesan Jay | Director | Grant(A) | 15K | — | $0 |
| Jun 12, 2026 | Wilson Karen J | Director | Buy(P) | 5K | $1.77 | $9K |
| Jun 11, 2026 | Wilson Karen J | Director | Buy(P) | 5K | $1.75 | $9K |
| May 26, 2026 | Ledger Steven A | Chief Executive Officer, Director | Grant(A) | 10K | $1.93 | $19K |
| May 22, 2026 | Wilson Karen J | Director | Buy(P) | 10K | $1.93 | $19K |
| May 22, 2026 | Venkatesan Jay | Director | Buy(P) | 589 | $1.78 | $1K |
| May 21, 2026 | Moreadith Randall | Chief Scientific Officer | Grant(A) | 86K | — | $0 |
| May 21, 2026 | Tenjarla Srini | SVP, CMC & Formulation | Grant(A) | 86K | — | $0 |
| May 21, 2026 | Curhan Gregory S | Chief Financial Officer | Grant(A) | 123K | — | $0 |
| May 21, 2026 | Ledger Steven A | Chief Executive Officer, Director | Grant(A) | 381K | — | $0 |
| May 21, 2026 | Wilson Karen J | Director | Buy(P) | 10K | $1.77 | $18K |
| May 19, 2026 | Marshall Richard Peter | Director | Buy(P) | 12K | $1.65 | $20K |
| Mar 31, 2026 | Venkatesan Jay | Director | Grant(A) | 8K | $1.94 | $15K |
| Mar 31, 2026 | Bailey Gregory | Director | Grant(A) | 60K | $1.94 | $116K |
| Mar 23, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 7K | $2.86 | $19K |
| Mar 23, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Mar 23, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | $0.06 | $390 |
| Mar 19, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 39K | — | $0 |
| Mar 19, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 39K | $2.50 | $98K |
| Mar 19, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 39K | $0.06 | $2K |
| Feb 3, 2026 | Moreadith Randall | Chief Scientific Officer | Grant(A) | 69K | — | $0 |
| Feb 3, 2026 | Ledger Steven A | Chief Executive Officer, Director | Grant(A) | 230K | — | $0 |
| Feb 3, 2026 | Tenjarla Srini | SVP, CMC & Formulation | Grant(A) | 69K | — | $0 |
| Feb 3, 2026 | Gill Simba | Director | Grant(A) | 92K | — | $0 |
| Feb 2, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Feb 2, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 7K | $3.03 | $20K |
| Feb 2, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | $0.06 | $390 |
| Jan 28, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Jan 28, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 7K | $3.57 | $23K |
| Jan 28, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | $0.06 | $390 |
| Jan 22, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 3K | $0.06 | $150 |
| Jan 22, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 3K | — | $0 |
| Jan 22, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 3K | $2.95 | $7K |
| Jan 21, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | $0.06 | $120 |
| Jan 21, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 2K | $3.00 | $6K |
| Jan 21, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | — | $0 |
| Jan 20, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 2K | $3.07 | $6K |
| Jan 20, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | $0.06 | $120 |
| Jan 20, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | — | $0 |
| Jan 14, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 1K | $2.50 | $3K |
| Jan 14, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 1K | $0.06 | $65 |
| Jan 14, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 1K | — | $0 |
| Jan 13, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Jan 13, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 5K | $0.06 | $325 |
| Jan 13, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 5K | $2.50 | $14K |
| Jan 8, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 13K | — | $0 |
| Jan 8, 2026 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 13K | $2.69 | $35K |
| Jan 8, 2026 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 13K | $0.06 | $780 |
| Dec 23, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 4K | — | $0 |
| Dec 23, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 4K | $0.06 | $246 |
| Dec 23, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 4K | $2.60 | $11K |
| Dec 22, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 6K | — | $0 |
| Dec 22, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 6K | $0.06 | $340 |
| Dec 22, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 6K | $2.67 | $15K |
| Dec 16, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 3K | — | $0 |
| Dec 16, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 3K | $0.06 | $194 |
| Dec 16, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 3K | $2.96 | $10K |
| Dec 12, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | — | $0 |
| Dec 12, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 2K | $3.26 | $6K |
| Dec 12, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | $0.06 | $102 |
| Dec 11, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 4K | — | $0 |
| Dec 11, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 4K | $0.06 | $213 |
| Dec 11, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 4K | $3.24 | $12K |
| Dec 10, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 645 | — | $0 |
| Dec 10, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 645 | $3.35 | $2K |
| Dec 10, 2025 | Moreadith Randall | Chief Scientific Officer | Grant(A) | 645 | $0.06 | $39 |
| Dec 9, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 600 | — | $0 |
| Dec 9, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 600 | $3.31 | $2K |
| Dec 9, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 600 | $0.06 | $36 |
| Dec 3, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 5K | $3.52 | $18K |
| Dec 3, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Dec 3, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 5K | $0.06 | $300 |
| Dec 2, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | — | $0 |
| Dec 2, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 2K | $0.06 | $90 |
| Dec 2, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 2K | $3.91 | $6K |
| Nov 25, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 6K | — | $0 |
| Nov 25, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 6K | $3.90 | $23K |
| Nov 25, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 6K | $0.06 | $358 |
| Nov 24, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 535 | — | $0 |
| Nov 24, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 535 | $0.06 | $32 |
| Nov 24, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 535 | $3.94 | $2K |
| Nov 18, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Nov 18, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | $0.06 | $390 |
| Nov 18, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 7K | $3.75 | $24K |
| Nov 10, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | — | $0 |
| Nov 10, 2025 | Moreadith Randall | Chief Scientific Officer | Sell(S) | 7K | $4.10 | $27K |
| Nov 10, 2025 | Moreadith Randall | Chief Scientific Officer | Option exercise(M) | 7K | $0.06 | $390 |
| Nov 7, 2025 | Marshall Richard Peter | Director | Grant(A) | 10K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Serina Therapeutics, Inc., SEC CIK 0001708599. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SER and shows every filing by that issuer (also filed as AGE).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-10. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SER